Max Robotics — Global Service Robot Directory + US Certification

About

Giuseppe Reitano is a leading urologic surgeon and researcher whose work is shaping the future of robotic surgery. His primary research areas focus on the perioperative, oncological, and functional outcomes of emerging robotic platforms in urology, with a particular emphasis on multiport and single-port systems. Reitano’s major contributions include comprehensive systematic reviews and meta-analyses that evaluate the safety and efficacy of new multiport robotic systems compared to the established Da Vinci platform, providing crucial evidence for surgical decision-making. His 2025 meta-analysis on new multiport robotic platforms, which has already garnered 20 citations, is a landmark study that benchmarks the performance of next-generation surgical robots. Additionally, his pooled analysis of the Da Vinci Single-Port system for adrenalectomy, with 6 citations, offers vital insights into the feasibility and outcomes of this innovative approach. Reitano’s work is instrumental in guiding the adoption of cutting-edge technology in urology, helping to improve patient outcomes and expand the horizons of minimally invasive surgery. His rigorous, evidence-based approach makes him a key voice in the field.